Piramal Pharma Limited provides results for Q4 and GJ2025
Piramal Pharma Limited (NSE: PPLPharma) (BSE: 543635), a leading global pharmaceutical and wellness company, reported its individual and group results for the fourth quarter (Q4) and the entire year (GJ)…